Results 151 to 160 of about 23,396 (211)

Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson's disease. [PDF]

J Lipid Res
Peng YF, Chen SJ, Li JL, Lin CH, Kuo CH.
europepmc   +1 more source

Specific organelle targeting as a key step in epidermal lipid synthesis. [PDF]

Front Med (Lausanne)
Schratter M, Radner FPW.
europepmc   +1 more source

Two G protein-coupled receptors bind ceramides in atherosclerosis progression: targets for a new therapeutic strategy. [PDF]

Signal Transduct Target Ther
Han Y, Illes P, Tang Y.
europepmc   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Exploring Ceramide C16:0 as a Novel Biomarker and Therapeutic Target for Atherosclerosis. [PDF]

J Am Heart Assoc
Chen T, Xie L, Zhao Y, Shang Y, Pan Y, Wang W, Mao W.   +6 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ceramide-epoxides

Chemistry and Physics of Lipids, 2001
Previously unknown 4,5-epoxy-N-acetyl-sphingosine (1) was synthesized by epoxidation of N-acetyl-sphingosine with 1,1-dimethyldioxirane. A by-product generated by HPLC purification is the tetrahydrofuryl derivative of acetamide (2). Mainly allylic oxidation was observed when natural ceramides were reacted with dimethyldioxirane.
A, Möllenberg, G, Spiteller
openaire   +2 more sources